Nakaya S, Yamamoto M, Kimata H, Saitoh Y
Jpn J Antibiot. 1985 Jan;38(1):160-5.
Comparative study of prophylaxis with cefotiam (CTM) was carried out in 47 patients undergoing surgery for gastric cancer. The patients were randomized in 2 treatment groups. The first group A received a single intravenous drip dose of 0.5 g CTM, given 4 times daily for 5 days after surgery. The second group B received a single intravenous drip dose of 1 g CTM, given twice daily for 5 days. Postoperative infections occurred in 8.7% (2/23) of the patients receiving CTM in group A, and in group B 8.3% (2/24). The number of infections was similar in both groups of patients. Prophylactic efficacy of CTM has also been evaluated in fever index of A and B groups. Fever index was 16.36 +/- 4.00 degree hours in A group, and in B group 7.91 +/- 2.30 degree hours, respectively. The difference between the 2 groups are statistically significant tendency. A single dose of 1 g CTM, given twice daily for 5 days, provide effective prophylaxis against infections in patients undergoing surgery for gastric cancer. CTM can be recommended for surgical prophylaxis.
对47例接受胃癌手术的患者进行了头孢替安(CTM)预防性用药的对比研究。患者被随机分为2个治疗组。第一组A接受单次静脉滴注0.5 g CTM,术后每天给药4次,共5天。第二组B接受单次静脉滴注1 g CTM,每天给药2次,共5天。A组接受CTM治疗的患者中术后感染发生率为8.7%(2/23),B组为8.3%(2/24)。两组患者的感染例数相似。还通过A组和B组的发热指数评估了CTM的预防效果。A组发热指数为16.36±4.00度时,B组为7.91±2.30度时,两组之间的差异有统计学显著趋势。单次给予1 g CTM,每天2次,共5天,可有效预防接受胃癌手术患者的感染。CTM可推荐用于手术预防。